Nityr Tablet
Product Images NDC 70709-005

Product Visual Gallery

This gallery contains 44 technical images submitted to the FDA as part of the official labeling for Nityr (NDC 70709-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cycle Pharmaceuticals Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Bottle Label)

NITYR® is a tablet containing nitisinone used for oral consumption. It is manufactured by PCI Pharma Services in the UK and marketed by Cycle Pharmaceuticals Ltd. The tablets should be kept in a tight, light-resistant container and stored at a temperature between 20°C to 25°C. The prescription drug should be kept out of reach and sight of children. Dosage and usage instructions can be found in the prescribing information. Lot number and expiry date are available but not provided in the text.*

FDA Label Image

Principal Display Panel (Bottle Label)

NITYR® (nitisinone) is a medication in tablet form for oral use, marketed by Cycle Pharmaceuticals Ltd based in Cambridge, UK. It is manufactured by PCl Pharma Services in Tredegar, UK. The medication should be dispensed in a tight and light-resistant container as defined in USP, and kept at a temperature range of 20°C to 25°C (68°F to 77°F). The tablets come in a bottle of 60 tablets and the NDC number is 70709-002-60. Dosage and use should be determined based on the prescribing information provided. The lot number and expiration date are both provided. The medication should be kept out of the reach and sight of children.*

FDA Label Image

Principal Display Panel (10 mg Bottle Label)

Cycle Pharmaceuticals Ltd markets this product, which is manufactured by PCl Pharma Services. It is recommended to store the drug in a tight and light-resistant container and at room temperature. The NDC number for this product is 70709-005-60, and it is to be used orally. Dosage and usage information can be found in the prescribing information. Keep this drug out of the reach and sight of children. A lot number is provided.*

FDA Label Image

Principal Display Panel (10 mg Carton)

This is a description of a medication called NITYR. It is marketed by Cycle Pharmaceuticals Ltd in the UK and is manufactured by PClI Pharma Services. The medication is in tablet form and each tablet contains 10mg of Nitisinone, along with inactive ingredients such as glyceryl dibehenate and lactose monohydrate. NITYR should be stored at room temperature and kept in a tightly sealed container. It is only available with a prescription and should be kept out of reach of children. For more information, refer to the prescribing information or contact Cycle Pharmaceuticals Ltd.*

FDA Label Image

Principal Display Panel (2 mg Carton)

This is a medication information sheet for oge o tablets, containing nitisinone 2mg, marketed by Cycle Pharmaceuticals Ltd. The sheet provides dosage instructions and contact information for questions or concerns. It also includes details about the inactive ingredients and storage instructions.*

FDA Label Image

Principal Display Panel (5 mg Carton)

This is a medication for oral use containing Nitisinone 5 mg. It is manufactured by PCI Pharma Services, Tredegar, NP22 3AA, UK and marketed by Cycle Pharmaceuticals Ltd, Cambridge, CB3 OFA, UK. The tablets come in a container that is tight and light-resistant and must be kept out of reach and sight of children. The medication can be stored at room temperature, and for dosage and use, one should refer to the prescribing information. For any questions or concerns contact Cycle Pharmaceuticals Ltd at 1-855-831-5413. NDC 70709-005-60.*

FDA Label Image

Ifu 1 (Ifu 01)

FDA Label Image

Ifu 2 (Ifu 02)

FDA Label Image

Ifu 3 (Ifu 03)

FDA Label Image

Ifu 4 (Ifu 04)

FDA Label Image

Ifu 5 (Ifu 05)

FDA Label Image

Ifu 6 (Ifu 06)

FDA Label Image

Ifu 7 (Ifu 07)

FDA Label Image

Ifu 8 (Ifu 08)

FDA Label Image

Ifu 9 (Ifu 09)

FDA Label Image

Ifu 10 (Ifu 10)

FDA Label Image

Ifu 11 (Ifu 11)

FDA Label Image

Ifu 12 (Ifu 12)

FDA Label Image

Ifu 13 (Ifu 13)

FDA Label Image

Ifu 14 (Ifu 14)

FDA Label Image

Ifu 15 (Ifu 15)

FDA Label Image

Ifu 16 (Ifu 16)

FDA Label Image

Ifu 17 (Ifu 17)

FDA Label Image

Ifu 18 (Ifu 18)

FDA Label Image

Ifu 19 (Ifu 19)

FDA Label Image

Ifu 20 (Ifu 20)

FDA Label Image

Ifu 21 (Ifu 21)

FDA Label Image

Ifu 22 (Ifu 22)

FDA Label Image

Ifu 23 (Ifu 23)

FDA Label Image

Ifu 24 (Ifu 24)

FDA Label Image

Ifu 25 (Ifu 25)

FDA Label Image

Ifu 26 (Ifu 26)

FDA Label Image

Ifu 27 (Ifu 27)

FDA Label Image

Ifu 28 (Ifu 28)

FDA Label Image

Ifu 29 (Ifu 29)

FDA Label Image

Ifu 39 (Ifu 39)

FDA Label Image

Ifu 40 (Ifu 40)

FDA Label Image

Ifu 41 (Ifu 41)

FDA Label Image

Ifu 42 (Ifu 42)

FDA Label Image

Ifu 43 (Ifu 43)

FDA Label Image

Ifu 44 (Ifu 44)

FDA Label Image

Ifu 45 (Ifu 45)

FDA Label Image

Ifu 46 (Ifu 46)

FDA Label Image

Figure 1 Structural Formula (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.